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LIST OF ABBREVIATIONS USED
BP - Blood pressure
ECG - Electrocardiography
IV - Intravenous
LA – Local anesthesia
VAS- Visual Analog Scale
ORIF – Open reduction and internal fixation
# - Fracture
MASTER CHART ABBREVIATIONS
HT- Hypertension
BB – Both bones
DM – Diabetes Mellitus
FA - Forearm
USG- Ultrasound
Deemed- Dexmeditomidine
Levo- Levobupivacaine
xABSTRACT
Background & Objectives:
The present clinical study was conducted to evaluate the onset of
analgesia, degree of sensory and motor blockade, duration of analgesia
and complications between Levobupivacaine and Levobupivacaine with
Dexmeditomidine in USG guided axillary brachial plexus block.
Methods:
The study was conducted on 60 ASA 1 and 11 patients of either sex
posted for various elective or emergency surgeries of the upper limb
involving elbow, forearm and hand surgeries. The subjects were divided
into two groups, group A receiving axillary brachial plexus block with
0.25% Levobupivacaine alone and group B receiving Levobupivacaine
with Dexmeditomidine 0.5μg /kg. Patients’ vital parameters were
monitored throughout the procedure and in the post-operative period for
48 hours. A  thorough  observation  was  made  on  onset, quality,
duration  of analgesia,  degree  of  motor  blockade and complications.
Result
The onset of sensory blockade (mean difference 0.04 minutes, p-value
<0.001) and motor blockade (mean difference 0.03 minutes, p-value
<0.001) were quicker in group B compared to group A. Both these
findings were statistically significant. Both the duration of sensory
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blockade (mean difference 4.7 hours, p value <0.001), and motor
blockade (mean difference 1.8 hours, p value <0.001) were longer in
group B compared to group A and both these findings were statistically
significant. Time taken for starting of regression (mean difference -1.37
minutes, p-value <0.108) was more in group B compared to group A, but
this finding was not statistically different. All other parameters related to
duration of anesthesia including time taken for full motor and sensory
recovery were longer in group B compared to group A. These differences
were statistically significant.
There were statistically significant differences in the duration of
complete analgesia, duration of effective analgesia and time of first pain
medication between the study groups. All these parameters were longer in
group B compared to group A.
The average post anesthesia hemodynamic parameters like heart rate,
systolic and diastolic pressures were higher in group A compared to
group B. The difference in the heart rate and diastolic blood pressure
were statistically significant. The post anaesthetic respiratory parameters
were almost similar in both the study groups.
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Interpretation and conclusion
In this prospective randomized double blinded case control study,
Levobupivacaine with Dexmeditomidine seems to be advantageous over
plain levobupivacaine in terms of onset, quality and intensity of sensory
and motor blockade. The duration of analgesia is both clinically and
statistically significantly prolonged in Levobupivacaine with
Dexmeditomidine group.
Keywords: Levobupivacaine, Dexmeditomidine, USG, Axillary brachial
plexus block.
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1INTRODUCTION
The techniques of peripheral nerve blockade were developed early in
the history of anesthesia. The US surgeons Halsted and Hall described
the injection of cocaine in to peripheral sites which include the ulnar,
musculo cutaneous, supra trochlear and infra orbital nerves for minor
surgical procedures in the1880s.1 James Leonard Corning
recommended the use of an esmarch bandage in1885to arrest the local
circulation; prolong the cocaine induced block, decrease uptake of that
local anesthetic from tissues. This concept was further developed by
F.W.Braun who substituted epinephrine, a chemical tourniquet in 1903.
He also introduced the term conduction anesthesia in his 1914 textbook
on Techniques of local anesthesia.
Peripheral nerve blockade remains a well-accepted component of
comprehensive anesthetic care. Its role has expanded from the operating
site into the arena of post-operative and chronic pain management.
Skillful application of peripheral neural blockade broadens the
anesthesiologists’ range of options in providing optimal anesthetic care.
The axillary approach to the brachial plexus is the most popular because
of its ease, reliability and safety. Blockade   occurs   at   the level   of
the   terminal nerves and although   blockade   of musculocutaneous nerve
2is not always produced with this approach, it can be supplemented at the
level of axilla or at the elbow.
Indication:
Indication for axillary block includes surgery on the elbow, forearm and
hand. This block is ideally suited for outpatients and is easily adapted to
the pediatric population.
The introduction of percutaneous axillary and supraclavicular
techniques by Herschel in 1911 was received enthusiastically during the
First World War because of them any upper extremity injuries resulting
from war. Brachial plexus block is widely used today to provide
anesthesia for upper extremity. There are four usual sites of approach
namely inter scalene, supraclavicular, infra clavicular & axillary.
Knowledge of formation of brachial plexus and its ultimate cutaneous
and muscular distribution is absolutely essential for the intelligent and
effective use of brachial plexus blockade for upper limb surgeries. Close
familiarity with the vascular, muscular and fascial relationships of the
plexus is equally essential to the mastery of various techniques; for it is
these peri neural structures which serve as the landmark by which needle
may accurately locate the plexus percutaneously. In its course from
3intervertebral foramina to the upper arm, the fibers are composed
consecutively of roots, trunks, divisions, cords and terminal nerves.
Formation of brachial plexus 2, 3
Brachial plexus is formed by the union of ventral rami of lower four
cervical   nerves   (C5,  6,  7,  8)  and  first  thoracic  nerve  (T1)  with
frequent contributions from C4 or T2. When contribution from C4 is
large and from T2 is lacking, the plexus appears to have a more cephaloid
position and is termed Pre fixed. When contribution from T2 is large and
from C4 is lacking, the plexus appears to have a caudal position and is
termed post fixed. Usually pre fixed or post fixed positions are associated
with the presence either of a cervical rib or of an anomalous first rib.
(Fig.1)
Roots
Represent the anterior primary divisions of lower four cervical and
first thoracic nerves. They emerge from the intervertebral foramina and
fuse above the first rib to form the trunks.
Trunks
The roots combine above the first rib to form the three trunks of the
plexus. C5 and C6 unite at the lateral border of the scalenus medius and
form the "Upper trunk", C8 and T1 unite behind the scalenus anterior to
4form "lower trunk" and C7 continues as a sole contributor to the "middle
trunk".
Divisions
As the trunks pass over the first rib and under the clavicle, each one of
them divides into anterior and posterior divisions.
Cords
The fibers, as they emerge from under the clavicle, recombine to form
three cords.  The "lateral cord" is formed by anterior divisions of upper
and middle trunks, lateral to the axillary artery. The anterior division of
lower trunk descends medial to the axillary artery forming the "medial
cord". The posterior divisions of all three trunks unite to form the
"posterior cord", at first above and then behind the axillary artery. The
medial and lateral cords give rise to nerves that supply the flexor surface
of upper extremity, while nerves arising from the posterior cord supply
the extensor surface.4 (Fig.2)
Major terminal nerves:
Each of these cords gives off a branch that contributes to or become one
of the major nerves to the upper extremity and then terminates as a major
nerve. The lateral and median  cords  gives off lateral and medial heads of
the median nerve and continue as major terminal  nerves, the lateral  cord
5terminating as musculo cutaneous nerve and medial cord as ulnar nerve.
Posterior cord gives off, axillary nerve as its major branch and then
continues as the radial nerve.
In summary, conveniently it can be considered that brachial plexus
begins with five nerves (C5-T1) and terminates in five nerves (Musculo
cutaneous, radial, axillary, median and ulnar nerves) with  its
intermediate portions displaying in sets of three that is, three main trunks
which divide into 2 sets of three, which reunite and give rise to three
cords. These three cords give off three lateral branches before becoming
the major terminal branches of the plexus. (Fig.3 and 4)
Distribution of brachial plexus: 5.6
These are divided into
A) Those that arise above the clavicle- the supraclavicular branches
and
B) Those that arise below it, the infraclavicular branches
Supraclavicular branches:-
From roots:
1. Nerves to scalenei and longus colli- C5.6, 7.8
2. Branch to phrenic nerve – C5
63. Dorsal scapular nerve – C5
4. Long thoracic nerve of Bell -C5, 6, (7)
From trunks:
1. Nerve to subclavius – C5, 6,
2. Supra scapular nerve-C5, 6
Infraclavicular branches:-
They branch from cords but their fibers may be traced back to
spinal nerves.
Lateral cord:
1. Lateral pectoral nerve- C5, 6, 7
2. Musculo cutaneous nerve – C5, 6, 7
3. Lateral root of median nerve- C5, 6, 7
Medial cord:
1. Medial pectoral nerve- C8, T1
2. Medial cutaneous nerve of arm –C8, T1
3. Medial cutaneous nerve of forearm – C8, T1
4. Medial root of median nerve- C8, T1
5. Ulnar nerve- C7, 8, T1
7Posterior cord:
1. Upper subscapular nerve-C5, 6
2. Lower subscapular nerve-C5, 6
3. Nerve to latissmusdorsi (Thoraco dorsal nerve) - C6, 7, 8
4. Axillary nerve-C5, 6,
5. Radial nerve- C5, 6, 7, 8, T1.
Supraclavicular branches:
As anesthesiologists, we must have complete knowledge of
distribution of sensory fibers to upper extremities in order to provide
surgical anesthesia appropriate for the procedure. We must also have
knowledge of motor nerves in order to provide muscular relaxation and a
motionless surgical field and also postoperative persistent neurological
defect can be determined by this wisdom.
1. The nerves to scalene and longus colli (C5, 6, 7, 8)
They arise from lower cervical ventral rami almost immediately
after emerging   from   the intervertebral foramina after receiving the
respective sympathetic nerve contributions. They supply – Longus colli
muscle (C2 - C7) Anterior scalene muscle (C4-C6) Middle scalene
muscle (C6-C8) Posterior scalene muscle (C6-C8) Scalenus minimus
muscle (C7-C8).
82. Branch to phrenic nerve: C5
A Branch from the fifth cervical nerve joins the phrenic nerve,
anterior to the scalenus anterior.
3. The Dorsal scapular nerve: C5
Arises from fifth cervical ventral ramus, pierces scalenus medius,
passes behind the levator scapulae and runs to rhomboids. It supplies -
Levator scapulae muscle C3-C5 - Rhomboid minor muscle C5 Rhomboid
major muscle C5
4. Long thoracic nerve (C5, 6, (7)):
It arises from C5, C6 and C7 in 42% of cases, C5 and C6 pierce the
scalenus medius, uniting lateral to it and descends dorsal to the brachial
plexus and first part of axillary artery. It crosses superior border of
serratus anterior and continue downwards to the lower border of serratus
anterior, supplying; branches to each of its digitations. It supplies -
serratus anterior muscle. Injury to this nerve causes scapular angle  to  be
drawn  medially by  unopposed action  of  rhomboids  and  levator
scapulae and tends to project (winging of the scapula) when horizontal
arm is used  for forward  pushing movements.  The arm cannot be raised
above the horizontal level.
9Branches from Trunks:
1. The nerve to subclavius (C5-6):
The nerve arises from C5 and C6 descends anterior to the plexus
and third part of subclavian artery and vein to reach subclavius muscle.
Accessory phrenic nerve may occasionally be a branch of this. It supplies
to subclavius muscle.
2. The suprascapularnerve (C5-6):
The nerve arises from superior aspect of the superior trunk and
runs laterally deep   to trapezius and omohyoid, enter supraspinous fossa
through the suprascapular notch and supplies: Supraspinatus muscle C5
and Infraspinatus muscles C5-6. Occasionally, it also supplies sensory
branches to the shoulder joint, the only sensory fibers that arise above the
clavicle. When present, it pierces the deltoid muscle and supply the skin
of the proximal third of the arm within the territory of the axillary nerve.
Because  of  its  position  superior  to  the  plexus,  this  nerve  may  be
stimulated during the subclavian perivascular technique, giving rise to
paresthesia to the shoulder, which cannot be relied upon. Because the
nerve leaves the plexus and  its  investment  fascia  shortly  after  arising
from  the  superior  trunk  and paresthesia in this distribution could
indicate stimulation of fibers before or after the nerve has left the sheath.
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Infraclavicular branches:
They comprise all of the motor and sensory nerves to the upper
extremity proper. Apart from some exceptions, there are no branches
arising from the divisions of plexus, Rest of the branches are from the
three cords.
Branches from the Cords:
A. Lateral Cord:
1) Lateral Pectoral nerve (C5, 6, 7)
It is larger than the medial pectoral nerve which passes superficial
to the first part of the axillary artery and vein, pierces the clavipectoral
fascia and supplies the pectoralis major. It sends ramus to the medial
pectoral nerve, to supply some fibers to the pectoralis minor. It supplies
Pectoralis major muscle (C5-T1).
2) The musculocutaneous nerve: (C5, 6, 7)
The musculocutaneous nerve is the major terminal branch of the
lateral cord. After giving off the lateral head to median nerve, it leaves
the plexus and enters coracobrachialis muscle. It courses through axillary
coracobrachialis muscle and descends obliquely and later between triceps
and brachialis, sending motor fibers to the two muscles. It pierces the
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deep fascia lateral to the tendon of biceps, just below the elbow and
continues as the lateral cutaneous nerve of the forearm. It supplies -
Coracobrachialis muscle (C6,7 )Biceps muscle (C5,6) Brachialis muscle
(C5,6) These are powerful flexor muscles of the forearm, paralysis of
which causes inability to  flex,  supinate and abduct the forearm. The arm
hangs in medial rotation; forearm is extended and pronated -"Erb's
paralysis". The lateral cutaneous nerve of the forearm supplies the skin
of forearm's anterolateral surface.
3) The median nerve:  (C6, 7, 8, T1)
The nerve arises from two roots, the lateral root of median (from
lateral cord) and medial root of median (From the medial cord). The two
roots straddle the third part of axillary artery before they unite on its
ventral surface. It descends along the course of the brachial artery. In the
arm it is first lateral to the brachial artery; medial to the cubital fossa
where it is posterior to the bicipital aponeurosis and anterior to the
brachialis. It enters the forearm between the heads of the pronator teres,
crossing lateral to the ulnar artery. It passes behind a tendinous bridge
between the two heads of flexor digitorum superficialis (FDS) descending
posterior to this muscle and anterior to flexor digitorum profundus. About
5 cm proximal to the flexor retinaculum (FR), it becomes superficial
between the tendons of the flexor digitorum superficialis and carpi
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radialis. Then it passes deep to flexor retinaculum into the palm to
terminate in muscular and cutaneous branches.
Muscular branches:-
Flexor digitorum profundus, Flexor pollicis longus, Pronator
quadratus, Pronator teres, Flexor digitorum superficialis, Flexor carpi
radialis, Opponens pollicis, Flexor pollicis brevis and Lumbricals.
Palmar cutaneous branches (Sensory) to Skin of palmar aspect
of thumb, the lateral two and middle half finger and distal end of the
dorsal aspect of the same fingers. It may encroach upon the area usually
innervated by radial nerve, also providing sensory innervations of the
dorsal surface of the entire thumb and first three fingers as far as
metacarpo phalangeal joint and an area supplied by ulnar nerve and may
provide sensory innervation of entire ring finger.
Articular branches are to the elbow joint and proximal radio ulnar
joint. Some of intercarpal, carpometacarpal and inter metacarpal joints
are said to be supplied by the branches of median nerve. Median  nerve
injury  can  occur  in  forearm,  proximal  to  its  muscular  and
interosseous branches, flexion of second phalanges of all digits is lost,
and of the terminal phalanges of index and middle fingers. Terminal
phalanges of other two fingers may be flexed by the part of flexor
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digitorum profundus, supplied by ulnar nerve. Proximal phalanges may
be flexed by the interossei.  The thumb cannot be opposed or abducted,
nor flexed at its interphalangeal joint. Sensation in the area of distribution
is lost.  Owing to paralysis of intrinsic pollicis muscles and unopposed
action of the extensor pollicis longus an "apelike" hand exists. Injury in
the mid-forearm may cause only weakness in flexion of the index
("pointing index") finger, as the branch to flexor digitorum superficialis
arise above this level. Injuries proximal to flexor retinaculum cause
inability to oppose the thumb. Any condition resulting in reduction in the
space below the flexor retinaculum causes pressure on the nerve in the
carpal tunnel, between flexor retinaculum and the carpal bones, resulting
in pain and slight sensory impairment in the digits supplied and
sometimes slight wasting of the thenar muscles.  This is called "carpal
tunnel syndrome".
B. Medial Cord:-
1) Medial head of median nerve (C8, T1)
It joins the lateral head from lateral cord to form the median nerve.
2) The medial pectoral nerve (C8, T1)
It passes between the axillary artery and vein, joins the lateral
pectoral nerve, forming a loop around the artery and enters the pectoralis
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minor muscle to supply it. Some fibers pass inferiorly to end in pectoralis
major.  It supplies pectoralis minor muscle C8, T1.
3) The medial cutaneous nerve of the arm (C8, T1)
It leaves the axillary sheath high in the axilla, where part of it
forms a loop with the intercosto brachial nerve, with which it has a
reciprocal relationship with respect to size and distribution. It supplies the
medial portion of the upper arm as far distally as the medial epicondyle.
Frequently   this   nerve   innervates   the   lower   portion   and   the
intercosto brachial nerve the upper portion.
4) The medial cutaneous nerve of the forearm (C8, T1)
Initially the nerve is between the axillary artery and vein and
supplies a ramus piercing the deep fascia to supply the skin over the
biceps almost to the elbow. It travels down the arm medial to the brachial
artery, dividing into a larger anterior branch and a posterior branch to
supply the skin over the entire medial aspect of the forearm as far as the
wrist.
5) The ulnar nerve: (C7) C8 T1
It runs distally through the axilla, medial to the axillary artery, till
the middle of the forearm, parallel to and between the median and medial
cutaneous nerve of the forearm. Then it angles dorsally and laterally to
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descend in groove on the medial head of the triceps. Then it passes
behind the medial epicondyle of the humerus, covered only by skin and
fascia ("Fussy bone") and passes down the ulnar side of .the forearm to
the hand, dividing into superficial and deep terminal branches.
Muscular branches supply (C8, T1)
Flexor carpi ulnaris, Ulnar head of flexor digitorum profundus,
Abductor digiti minimi, Flexor digiti minimi brevis, Abductor pollicis,
Palmar interossei, Dorsal interossei.
Articular branches to elbow, wrist joint, intercarpal,
carpometacarpal and intermetacarpal joints.
Cutaneous branches supply the skin of the medial two and half
fingers of the hand. The ulnar nerve may be injured in the forearm
leading to impaired abduction; when attempt is made to flex the wrist.
The hand is abducted by the flexor carpi radialis, owing to paralysis of
the dorsal interossei, the fingers cannot be   spread   or   flexed   at
metacarpo phalangeal   joints   or   extended   at   the interphalangeal
joints, and the arm assumes a "clawed" shape from the active opposing
muscles. Flexion of the fourth and fifth digits is weakened and the thumb
cannot adduct. Wasting of the hypo thenar muscles will occur. Sensation
is lost or impaired on the skin supplied by the nerve.
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C. Posterior Cord:
1) The upper sub scapular nerve (C5, 6)
2) The thoraco dorsal nerve (C5-6)
3) The lower subscapular nerve (C5, 6)
4) The axillary (circumflex humeral) nerve (C5-6)
It supplies the deltoid, teres minor and the upper part of the long
head of triceps. An articular branch supplies the shoulder joint. The
axillary nerve is liable to injury in its course around the surgical neck of
humerus causing paralysis of deltoid and anesthesia of the skin over the
lower part of the muscle. Effective abduction of the arm is not possible.
5) The radial nerve (C5,6,7,8) It is the largest branch of the
brachial plexus, is the terminal continuation of the posterior cord. It
descends behind the third part of the axillary artery. With the profunda
artery, it inclines dorsally between the long and medial head of the triceps
then passes obliquely across the back of the humerus in the musculo
spiral groove and then reaches the lower anterior side of the forearm
where its terminal branches arise. Muscular branches supply the extensor
compartment of arm, fore arm and hand.
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Sympathetic contribution to brachial plexus:
The segmental preganglionic sympathetic contributions are
variable, but generally extend more caudal.  The highest contribution is
usually T2 with T1 contributing only rarely, while lowest may be as far as
T8, T9 or even T10. The post ganglionic contributions are from grey rami
communicantes from the sympathetic chain.
Cutaneous nerves of upper limb:
Cutaneous branch of lateral supraclavicular nerve supplies skin
over the upper half of the deltoid. Lateral cutaneous nerve of the arm
(terminal branch of the axillary nerve) supplies the skin over the lower
half of the deltoid, lateral, antero-lateral &postero-lateral aspects of the
arm. Twigs from the lateral& posterior cutaneous nerves of
forearm supply the arm near the cubital  fossa at  their
corresponding areas.
Intercosto brachial nerve supplies a small area near the medial
aspect of the axilla. Medial cutaneous nerve of the arm supplies the rest
of the medial, antero-medial and posteromedial aspects of the arm
.Twigs from the medial cutaneous nerve of the forearm supply the arm
near the cubital fossa. Posteriorly a strip of skin along the middle 1/3 is
innervated by the posterior cutaneous nerve of the arm. The skin of the
front of the forearm is supplied by the medial and lateral cutaneous
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nerves of the forearm.
The area of supply of these nerves extends on the back of the forearm.
But unlike the arm, major part of the skin of the back of the forearm is
supplied by the posterior cutaneous nerve of the forearm. (Fig.5)
Cutaneous Nerve Supply of the Hand:
Small part of the palmar aspect of the hand near the wrist is
supplied by the lateral and medial cutaneous nerves of the forearm; dorsal
aspect is by the posterior cutaneous nerve of the forearm. Major part is
supplied by the cutaneous   branches of the median, ulnar and radial
nerves. The ulnar nerve supplies the palmar & dorsal aspect of medial
one and half fingers. The median nerve supplies the palmar aspect of
lateral three and half fingers and distal phalanges of dorsal aspect. The
rest of the dorsal aspect of lateral 31/2 fingers is supplied by the radial
nerve.
19
Anatomy of the peripheral nerve
Each peripheral nerve axon possesses its own cell membrane, the
axolemma, within which is contained the axoplasm. Non myelinated
nerves such as autonomic postganglionic fibers are also encased in a
Schwann cell sheath. Most motor and sensory fibers are also wrapped in
several layers of myelin, a lipoid insulating membrane that separates the
axon itself from the Schwann cell sheath. Myelin greatly increases the
speed of nerve conduction by producing saltatory conduction via the
nodes of Ranvier, which are periodic interruptions in the myelin sheath.
A typical peripheral nerve consists of several groups of axons.
Each axon has its own connective tissue covering called endometrium. A
group of 100 to 1000 axons are bound together in bundles called
fasciculus. Each fasciculus consists of 5-15 layers of fibro elastic tissue
called perineurium. This perineurium is thicker at peripheral sites (i.e., at
the wrist than at the axilla). The innermost layer of the perineurium is a
smooth mesothelial membrane called perilemma. This is the main
diffusional barrier. A collection of 5 to 20 fasciculi are surrounded by the
outer sheath called the epineurium. This epineurium  lies in a matrix
called  epineural  space  which   consists of  loose  areolar  tissue,
nutrient  blood  vessels, lymphatics and fat.
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Structure of the axonal membrane: 7
Daniell-Davson- Robertson theory says that biologic membranes
consist of a bimolecular lipid layers, sandwiched between non lipid
proteinaceous monolayers. Probably the most widely accepted current
membrane model is that of Singer and Nicholson. According to this
theory each axonal membrane consists of
1. Lipid matrix (bimolecular in nature) containing long chain fatty acids
with polar heads (Phospho tidyl choline and phosphotidyl inositol)
2. Long lipid chain, being oriented towards the middle of the bi lipid
layer.
3 Bimolecular lipid layer. This layer contains proteins adsorbed on the
surfaces as well as embedded in or spanning the hydrocarbon core. The
bilayer character is due to amphophilic phospholipids which have long
hydrophobic fatty acyl tails  which lie in the center of the membrane, and
polar hydrophilic head groups  composed  of   Zwitter  ionic  (Containing
positive  and  negative  charges) components, which project in to the
cytoplasm or the interstitial fluid. Within the membrane there is lateral
and rotational diffusion, which allows lipids and proteins to migrate in a
fluid mosaic. Despite this general behavior, some proteins are fixed with
in specific regions of a membrane; sodium channels, for example, are
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highly localized at the nodes of Ranvier of Myelinated axons. A dynamic
interaction exists between the cell's membrane and cytoplasm.
Cytoplasmic enzymes may be regulated by hormone and neurotransmitter
receptors in the membrane. The membrane lipids behave as second
messengers, and the membrane proteins, are chemically altered and
physiologically modulated by intracellular enzymes such as kinases
which specifically phosphorylate certain proteins.
PATHWAYS OF PAIN:-
1) From skin and superficial structures:
a. The laminiscal system:
The sensation passes from sensory nerve to the dorsal horn of the
spinal cord then to lateral spino thalamic tract of other side to the lateral
nucleus of thalamus and reaches the post central gyrus of cortex
b. The extra laminiscal system:
Part of the spino thalamic tract goes to reticular formation which is
distributed to cerebral hemispheres through the thalamo- cortical
projection.
2) From muscles, tendon and bone:
Same pathway.
23
3) Visceral Pain:
The visceral pain is transmitted through the sympathetic chain and
white rami communicantes to the dorsal root ganglia.
4) There is evidence that different types of fibers are carried by the
sympathetic nervous system which may not correspond to somatic
segment. This may explain the pathway of tourniquet pain. (Fig.6)
Physiology of nerve conduction:
The neural membrane maintains a trans membrane potential of 60
to 90 mV by means of sodium impermeability& potassium permeability.
The ‘sodium -potassium pump’ (active& energy dependent mechanism)
maintains this potential difference by constant expulsion of sodium from
the cell. Although the membrane is freely permeable to potassium ions,
an intra to extra cellular potassium ratio of 150 mEq to 5 mEq per liter or
30:1 is maintained because of the active exchange of intracellular sodium
for extracellular potassium.
According to the Nernst equation, the nerve at rest behaves like a
potassium electrode. During normal excitation (depolarization) of a nerve
the Na+ permeability increased   followed by RMP (resting membrane
potential) altered from -90 to -50 mV. This -50 mV is called CTP (critical
threshold potential).
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At CTP of -50 mV, Na+ influx occurs rapidly with a counter
balance of K+ efflux.  Because of this RMP reverses from -50 mV to
+30 mV at a duration of 0.1- 0.2 m Sec which causes conduction of the
depolarization along the entire length of the nerve.  At 0.4- 0.6mSec
Na+ permeability rapidly decreases resulting Na+ efflux &K+ influx.
Therefore RMP of -90 mV reestablished. The ionic fluxes during
depolarization and repolarization are passive phenomena, because each
ion is moving down its own concentration gradient. The conduction of
the impulses is all or none phenomenon (if the CTP is  not
achieved dur ing a  loca l  depolar iza t ion then conduction of the
impulse will not occur.)25
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LEVOBUPIVACAINE HCL
Fig.7
Levobupivacaine is an amino-amide local anaesthetic drug
belonging to the family of n-alkyl substituted pipe coloxyl idide. It is the
S-enantiomer of bupivacaine, first synthesized by Brian Albert Gennery
in the year of 1997 and patented at 2002.
Other Names:
Also known as: Chirocaine, L (-)-Bupivacaine, (S)-bupivacaine,
Levobupivacaine, and Novabupi.
CHEMCIAL NAME:
(S)-1-butyl-N-(2, 6-dimethylphenyl) piperidine-2-carboxamide
Molecular Formula: C18 H28 N2 O
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PHYSICO CHEMICAL PROPERTIES:
PKa 8.1
Onset Slow
Relative lipid Solubility 1000
Potency High
Protein binding 95%
Duration of action Long.
BNF (British National Formulary) – Max. Dose 150 mg
Levobupivacaine is a colorless solution with a bitter taste and
molecular weight288.43 g/mol. It is soluble in water and alcohol and
insoluble in ether. It is stable in the presence of alkalis and acids and can
withstand heat sterilization and autoclaving.
Advantages of levobupivacaine than racemic bupivacaine include15, 54
1.  Rapid absorption from the site of injection32
2.  Rapid onset of action
3.  Wide and rapid spread
4. Lesser cardio toxicity31, 46, 55, 56
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5.Nonirritating, without accumulation of the drug or its metabolic
products. 37
6.  Stability permitting heat sterilization.
7. Less vasodilation and has a longer duration of action. It is
approximately 13 per cent less potent (by molarity) than racemic
bupivacaine.34
Target:
Inhibition of sodium channel protein type 10 subunit alpha in the
neuronal membrane (Whereas racemic bupivacaine inhibits beta
subunits). 23,24
Action:
Reversible inhibitor of sodium channel.
General Function:
Involved in ion channel activity
Indications
Levobupivacaine is indicated for local anesthesia including
infiltration nerve block, labor analgesia47, ophthalmic, epidural and intra
thecal anesthesia in adults and infiltration analgesia in children.
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Contraindications
Levobupivacaine is contraindicated for IV regional anesthesia
(IVRA).
Adverse effects
Adverse drug reactions (ADRs) 49, 50 are rare when it is
administered correctly. Most ADRs relate to administration technique
(resulting in systemic exposure) or pharmacological effects of anesthesia
(PH, protein binding and relative lipid solubility), however allergic
reactions can rarely occur. Systemic exposure to excessive quantities of
bupivacaine mainly result in central nervous system (CNS) and
cardiovascular effects – CNS effects usually occur at lower blood plasma
concentrations and additional cardiovascular effects present at higher
concentrations, though cardiovascular collapse may also occur with low
concentrations. CNS effects may include CNS excitation (nervousness,
tingling around the mouth, tinnitus, tremor, dizziness, blurred vision,
seizures16, 38) followed by depression (drowsiness, loss of consciousness,
respiratory depression and apnea).33, 42 Cardiovascular effects include
hypotension, bradycardia, arrhythmias and/or cardiac arrest– some of
which may be due to hypoxemia secondary to respiratory depression but
of less pronounced than racemic bupivacaine.40, 41, 43
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Peripheral nerve blocks
It was found that giving high concentrations of levobupivacaine
(0.5% -0.75%) increases the quality and duration of the block as well as
significantly reduces the time of onset. Higher concentrations of
levobupivacaine i.e., 0.5%–0.75% speed up the onset, and increase the
duration and quality of peripheral nerves blockade (Cox et al) 64
Like epidural catheter, in nerve blocks also, using continuous
catheters and administration of levobupivacaine gave very good results
and decreased the systemic opioid requirements in post-op analgesia.
Adjuvants like opioids, epinephrine, clonidine and dexmeditomidine,
when added with levobupivacaine, will enhance the quality and safety of
the block. However since the duration of action of levobupivacaine is
longer (10-12 hours), the need of epinephrine has reduced clinical
importance. But since epinephrine causes vasoconstriction; it may help in
two ways.
1. Reduces the risk of systemic toxicity if there is an accidental overdose.
2. It also signals the inadvertent intravascular injection.52
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Structural activity relations and physiochemical properties 1, 2
1) Lipophilic versus hydrophilic balance:
It depends on altering the site of alkyl substitution in the vicinity of
either the tertiary amine or the aromatic ring system. Substances of more
lipophilic nature are obtained by increasing the size of alkyl substitution.
These agents are more potent and longer lasting than their more
hydrophilic congeners.
2) Hydrogen ion concentrations:
This  depends  on  the  pH,  pK-a  of  the  local  anaesthetic  and
pH  of  the surrounding tissue as mentioned earlier.
3) Minimum anaesthetic concentrations (Cm):
The minimum anaesthetic concentration of the anaesthetic agent
necessary to block the impulse conduction along a given nerve fiber
within a reasonable standard period of time is termed minimum
anaesthetic concentration. The concentration lower than  the  minimum
anaesthetic  concentration  will  not  inhibit  conduction  at  all. Minimum
anaesthetic concentration values reflect the relative potencies of various
drugs. Changes in the electrolyte concentration and acid base status may
affect the minimum anaesthetic concentration. Therefore minimum
anaesthetic concentration is a standard of local anaesthetic potency,
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analogous to minimum alveolar concentration of the inhaled anaesthetic
agents. A variety of factors may affect minimum anaesthetic
concentration:
a) Fiber size:
Larger the nerve fiber, higher the concentration of local anaesthetic
required for inhibition of impulse conduction and their minimum
anaesthetic concentration values will be relatively high.
b) PH:
Minimum anaesthetic concentration of a given local anaesthetic is
less at a high pH than at a low pH. In a sheathed nerve, Cm for lidocaine
is 100 times more/less at pH 7 than at pH 5.
c) Calcium ion concentration:
Local anaesthetic potency correlates directly with the inhibition of
calcium binding by phospholipids. The local anaesthetic effect of most of
the drugs is inversely proportional to the calcium concentrations.
d) Nerve stimulation rate:
In vitro, individual anaesthetic potency is directly proportional to
the rate of nerve stimulation, a greater apparent potency being noted at
high stimulation rate.
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The electrophysiological effect of local anaesthetics:
The  resting  membrane  potential  of  a nerve  is  affected  by  the
various concentrations of the local anaesthetics. As the concentration of
the drug applied to the nerve is increased, a decrease in the rate and
degree of depolarization is produced. Inhibition of depolarization
increases with the time as the concentration of the drug is maintained.
Since both the rate of repolarization and the conduction velocity are
decreased and the refractory period is prolonged, the number of action
potentials that a nerve is capable of transmitting per unit of time
decreases as the drug concentration increases until complete block is
achieved when the nerve is unable to depolarize to the threshold potential.
The more important of the above mechanism is reduction in the rate of
depolarization during action – potential development.
The above effects of local anesthetics are a direct consequence of
inhibition of membrane conductance of sodium and potassium ions.
Pharmacological effects of local anesthetics:
a) Local -
Cause local nerve blockade and direct effect on smooth muscles.
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b) Regional
Loss of pain, temperature, sensation, touch, motor power,
vasomotor tone in the region supplied by the nerves blocked.
c) Cardiovascular
Lidocaine and procaine have a stabilizing effect on the cardiac cell
membrane. They tend to decrease the automaticity in abnormal or
damaged heart fibers and thereby suppress cardiac dysrhythmias.
Procaine and procainamide also have quinidine like action, prolong the
effective refractory period, slowing conduction and desynchronizing
ventricular contraction with consequent depression effect on myocardial
contractility. The mechanism involves effect on ionic conduction in
myocardium and smooth muscular conducting membrane and on
myocardial conducting system.53
Over dosage has been associated with ventricular tachycardia,
fibrillation and cardiac arrest. There is evidence however that cardiac
toxicity does not occur in sub convulsive doses or in the absence of
severe electrolyte imbalance or respiratory metabolic acidosis. On
vascular smooth muscles, local anesthetics may have local, regional or
systemic effect. Usually they cause vasoconstriction at lower
concentrations and vasodilatation at   higher concentrations. These
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changes   were   associated   with simulation and inhibition respectively
of tissue bound Ca 2+ ion release. The regional effect is simple
vasodilatation in the area supplied by blocked sympathetic nerves.
Systemic effects produced by large doses may produce circulatory
collapse as a result of medullary depression and of convulsions causing
respiratory impairment, rather than because of any direct effect on the
circulation.
d) Central nervous system-
Cocaine has undoubted stimulant effects which are unrelated to its
local anaesthetic action. The synthetic agents produce sedation and light
headedness. Sometimes anxiety and restlessness may occur in which case
inhibitory neurons have proved more susceptible than excitatory ones to
depression. With more marked toxicity, tinnitus, visual and auditory
disturbances, restlessness, slurred speech, nystagmus, shivering muscle
tremors.
Progression of dosage and serum level beyond this results in the
development of  EEG   seizure  activity  with  tonic  and clonic
convulsions  followed  by CNS depression.51 Toxic levels probably
initially lead to depression of cortical inhibitory pathways, allowing
unopposed activity of an excitatory nature. This transitional state of
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unbalanced excitatory and inhibitory activity is followed by generalized
CNS depression if higher serum levels are reached.
e) Autonomic nervous system
Cocaine has a sympathetic potentiating effect by inhibiting
catecholamine uptake. Other local anesthetics do not block nor-adrenaline
uptake.  Experimentally   local anesthetics possess a   weak binding
effect   on cholinergic and adrenergic receptors. The former may account
for bronchodilator effect.
g) Neuromuscular junction
They block motor nerves if present in sufficient concentration and
the presynaptic blocking effect has been observed under experimental
conditions with high procaine, again reflects a membrane stabilizing
action.
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DEXMEDITOMIDINE
Dexmeditomidine is the d-enantiomer of medetomidine, a
substance that has been used for sedation and analgesia in veterinary
medicine for many years. It was introduced in 1999 and used as a short-
term sedative of less than one day for mechanically ventilated critical
care patients. Nowadays it is used as sedative and adjuvant analgesic in
the OT, sedation in diagnostic and procedure units, and for other
applications such as withdrawal/detoxification amelioration in adult and
pediatric patients.
Physicochemical Characteristics58
It has a highly selective specificity for shows α2 receptor (α2/α1
1600: 1) whereas clonidine has a ratio of 200: 1 only and therefore it is an
absolute α2 agonist. It belongs to the imidazole subclass of α2 receptor
agonists and a water soluble drug.
Chemical structure of Dexmeditomedine
Dexmeditomedine hydrochloride is the S-enantiomer of
medetomidine and is chemically described as (+)4-(S)-[1-(2, 3-
dimethylphenyl) ethyl) -1H-imidazole mono hydrochloride.  Has a
molecular weight of 236.7 and the empirical formula is C13H16N2 • HCl
and the structural formula is:
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Fig.8
Metabolism and Pharmacokinetics
Dexmeditomidine is rapidly distributed and extensively
metabolized in the liver and excreted in urine and feces. It undergoes
conjugation (41%), n-methylation (21%), or hydroxylation followed by
conjugation. It has 94% protein binding capacity and the concentration
ratio of whole blood to plasma is 0.66. Dexmeditomidine has profound
effects on cardiovascular variables and may alter its own
pharmacokinetics. With large doses, there is marked vasoconstriction,
which probably reduces the drug's volumes of distribution. The
elimination half-life of Dexmeditomidine is 2 to 3 hours, with a context-
sensitive half-time ranging from 4 minutes after a 10-minute infusion to
250 minutes after an 8-hour infusion.
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Pharmacology12, 13
Dexmeditomidine is a nonselective α2 agonist.α2 adrenoreceptors
are membrane-spanning G proteins. Intracellular pathways include
inhibition of adenylate cyclase and modulation of ion channels There are
three subtypes of α2 adrenoreceptors namely α2A, α2B and α2C. The
α2A receptors are found in peripheral blood vessels whereas α2B and
α2C are found in the brain and spinal cord. Postsynaptic α2
adrenoreceptors in peripheral blood vessels will produce vasoconstriction,
whereas presynaptic α2 adrenoreceptors inhibit the release of
norepinephrine. The main response to α2 agonists is because of
stimulation of α2B and α2C which are located in the CNS and spinal
cord.19 These receptors are involved in the sympatholysis, sedation, and
anti-nociception effects of α2 adrenoreceptors.
Atipamezole:
This is a specificα2 antagonist. Dexmeditomedine effects are
reversed at 75-150μg /kg dose (Sympatho activation). This not approved
by US FDA at present because altepamezole is still under trial stages
only.
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Effects on the Central Nervous System
They are as follows:
1. Sedation
2. Anxiolysis
3. Hypnosis
4. Analgesia
5. Sympatholysis.
Sedation
Sedation is caused due to α2 agonism in the locus caeruleus10, 11
whereas analgesic action is due to agonistic action on the α2 receptors
within the locus caeruleus and within the spinal cord. The quality of
sedation produced by Dexmeditomedine seems different compared with
that produced by other sedatives acting through the GABA systems.
Patients receiving dexmeditomedine infusions as part of their sedation
regimen in the postoperative ICU setting have been described as being
very easy to wake up and having the ability to follow commands and
cooperate while being tracheal intubated. Undisturbed, patients were
noted to fall asleep right away. Even though there is marked sedation, the
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risk of respiratory depression is very minimal and hence the drug has high
safety margins.
Analgesia
The main site of action is the spinal cord.9, 11
Cardiovascular effects: 59
It decreases the heart rate, systemic vascular resistance, myocardial
contractility, stroke volume, and blood pressure. By developing highly
selective α agonists, it has been hoped to decrease some of these adverse
cardiovascular effects and to maximize the desirable hypnotic-analgesic
properties. Dexmeditomedine shows a characteristic biphasic response in
hemodynamics. An acute IV injection of 2 µg/kg resulted in an initial
increase in blood pressure (22%) and decrease in heart rate (27%) from
baseline that occurred at 5 minutes after injection. This initial increase in
blood pressure is probably due to the vaso constrictive effects of
Dexmeditomedine when stimulating peripheral α2 receptors.14 Heart rate
returned to baseline by 15 minutes, and blood pressure gradually declined
to approximately 15% below baseline by 1 hour. After an IM injection of
the same dose, the initial increase in blood pressure was not seen, and
heart rate and blood pressure remained within 10% of baseline.
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Infusion of Dexmeditomedine in volunteers also has been shown to
result in a compensated reduction in systemic sympathetic tone without
changes in baro reflex sensitivity. It also blunts the heart rate and
systemic sympathetic activation owing to sweating, but is less effective in
blunting cardiac sympathetic response to shivering. Hypotension and
bradycardia occurs mainly due to the loading dose. Giving less than 0.4
µg/kg of loading dose and giving slowly over 20 minutes will reduce the
severe fall in blood pressure. A frequently reported side effect of
Dexmeditomedine has been a dry mouth. Dry mouth is due to a decrease
in saliva production.
Uses
1. Short-term sedative for adult intubated patients in the ICU.
2. Because of its proven beneficial effects like anxiolysis, sedation,
analgesia, and sympatholysis with minimal respiratory depression,
it is very useful in peripheral nerve blocks.17, 18,20,21,22
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ULTRASOUND
Ultrasound is revolutionizing regional anesthesia techniques that
provide anesthesia and postoperative analgesia for patients undergoing
surgery. Almost every nerve block previously performed using traditional
localization techniques (paresthesias or nerve stimulation) can now be
performed using real-time ultrasound guidance. Unlike other localization
techniques, ultrasound allows the visualization of nerves and surrounding
structures as well as visualization of the needle and local anesthetic.
Basic Ultrasound Physics:
Ultrasound refers to high-frequency waves produced by passing
electricity through piezoelectric elements. These elements vibrate at a
high frequency creating ultrasound waves. It is therefore mechanical
vibrations of matter-sinusoidal waves-propagated at frequencies inaudible
to the human ear (> 20,000 Hz). The human ear hears sounds between 20
Hz (low sound) and 20,000 Hz (High pitched sound). We talk about
ultrasound when the vibration frequency is greater than 20,000 Hertz
(Hz), and generally ultrasound used in medicine has frequencies of above
1 MHz (between 1 to 25 MHz). The waves leave the ultrasound probe
and enter the body. These waves can then be reflected, refracted,
scattered, or absorbed depending on what internal structures they
encounter. (Fig.9)
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The ultrasound probe senses the reflected ultrasound waves, and
ultrasound images are generated from these reflected waves.
If a needle or nerve is 90 degrees perpendicular to the ultra- sound wave,
it will appear much brighter on the ultrasound image than a needle or
nerve at 45 degrees to the ultrasound wave.
Probe Selection:
The type of sensor that is used determines the quality of the resulting
image and the depth at which one can visualize anatomical structures.
The high frequency linear probes (10- 18 MHz) are used to perform
superficial blocks with high resolution images.  Penetration does not
exceed a 6 cm depth.
The low frequency convex probe of 3-8 MHz allows the construction of
deeper blocks, penetrating 10 -20 cm depth. It also allows a greater field
of vision with a small contact area due to the layout of the surrounding
crystals. (Fig.10)
Frequency:
Most sensors can emit at different frequencies. This frequency should
be adjusted on a case by case basis, depending on the depth of the block
to achieve and on the echogenicity of the patient. In general for a very
superficial block, it is often useful to choose a very high frequency and
the opposite for a deep block.
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Machine Settings:
There are only three settings to remember
• General (Gen): General imaging frequency—this is best for most
blocks.
• Resolution (Res): High-frequency imaging—this is best for
shallow blocks.
• Penetration (Pen): Low-frequency imaging—this is best for deep
blocks.
For each probe, the image quality and penetration can simply be adjusted
by using the Gen/Res/Pen settings (Fig.11).
Depth:
The depth should be adjusted so the nerve target is in the middle of
the screen. Most ultra- sounds are preset with the focal zones in the
middle of the screen. Focus allows the best lateral resolution possible,
improving image quality. This means you will have the clearest image of
your target if it is in the middle of the screen. Use the depth settings so
the needle and nerve are in the middle of the screen when possible. Some
machines require manual adjustment of focal zones.
Focus:
Ultrasound beams can be focused much like light can be focused
through a lens on a camera. Just like a photograph, when ultrasound
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images are out of focus, images can appear less sharp. Correct focus
improves lateral resolution.
Focus position affects image quality. The identical inter scalene
anatomy is scanned on 2 images. On the left the focus is set deep and on
the right the focus is set shallow. The nerves are easier to identify on the
right, where the focus is set at the same depth as the nerve roots in the
inter scalene groove (Fig.12).
Gain:
Gain adjusts screen brightness. There are no specific rules to adjust
the gain. Usually, each person will have a preference for gain settings.
Some general suggestions include the following:
1. The brightness of the screen should be adjusted so vascular
structures appear dark or anechoic.
2. Too much gain results in artifacts such as reverberation that can
“repeat” bright structures, such as fascial planes and obscure
targets.
3. Because ultrasound beams returning from deeper structures
become attenuated (or return a weaker signal), increasing the distal
gain can be helpful.
Over- and under-gained images:
The center image demonstrates the bright radial nerve in the center.
The under-gained image of the same nerve above is very dark, and the
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over-gained image below is very bright. Both over- and under-gain lose
vital detail (Fig.13 and 14).
Color Doppler:
Color Doppler allows visualization of flow. Flow can be arterial,
venous, or even from injection of local anesthetic.26 It is very important to
remember that the red or blue color on the screen does not signify
oxygenated (arterial) blood or deoxygenated (venous) blood. If a structure
appears red when using color Doppler, this signifies that the fluid is
moving toward the probe. If a structure appears blue when using color
Doppler, the fluid is moving away from the probe (Fig.15).
Sometimes there will be no color in a structure that may be a blood
vessel. The Doppler principle works best when the probe is parallel to the
blood flow, and there must be an angle between the flow of the blood and
the probe of less than 90 degrees. The Doppler equation uses the cosine
of the angle between the probe and the flow. The cosine of 90 is 0. This
means if the probe is at 90 degrees to the calculated flow, the measured
blood flow will be zero and there will be no color on the screen. The
probe must be tilted in one direction or the other to better visualize blood
flow with color Doppler. When performing nerve blocks, it is often
beneficial to move the Doppler box not only over the large artery but also
over the path the needle will take toward the nerve. Moving the Doppler
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box over the projected needle path prior to needle insertion will help
identify smaller vessels and prevent accidental vascular puncture.
How to visualize nerves and needles?
Long Axis vs. Short Axis
The term axis in ultrasound guided regional anesthesia is used to
describe the view obtained of a structure (nerve or vessel) in relation to
the ultrasound beam. A long-axis view is an image along the length of the
nerve, and a short-axis view cuts across the diameter of the nerve. In
ultra- sound guided regional anesthesia, we generally try to obtain a
short-axis view of the nerve.
In-Plane vs. Out-of-Plan
The term “plane” in ultrasound guided regional anesthesia is used
to describe the needle position relative to the ultrasound beam. Most
nerve blocks are performed with an in-plane approach. If performed
correctly, in-plane approaches allow the entire needle (shaft and tip) to be
visualized. This allows the user to place the needle tip with the greatest
amount of confidence and, potentially, the greatest amount of safety. Out-
of-plane needle approaches most closely resemble needle approaches
used for many years when paresthesias or nerve stimulation was used to
locate nerves. Some people prefer out-of-plane needle approaches
because they are more comfortable with the traditional approaches to
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locate nerves. However, out-of-plane nerve blocks do not visualize the tip
of the needle at all times and, therefore, potentially do not offer the same
level of confidence and potential safety that comes with always knowing
where the needle tip is located (Fig.16).
Out-of-Plane Technique (sliding)
The probe should be held over the target. Now the needle is advanced
slowly in shallow plane with the bevel up (to make it maximally visible).
We should look carefully for the hyper echoic dot as the needle cuts the
plane of the beam. Advancing of the needle is stopped immediately. The
probe is slide forward beyond the needle tip. Needle angle is increased
appropriately and now the needle is advanced again, looking carefully for
the hyper echoic tip. As soon as the needle tip is visible, we should stop
the needle. The process is repeated until the needle descends down on to
the target (Fig.17).
Out-of-plane technique (tilting):
The probe should be held over the target with the probe tilted
away from the needle. This increases the reflection from the needle and
allows room to tilt the probe toward the needle as it is advanced. Now the
needle is slowly advanced in a shallow plane with the bevel up. Any
hyper echoic dot should be carefully looked out as the needle tip appears
on the screen. As soon as the needle is visible, it should be stopped
immediately. Now the probe is tilted to ensure that the ultrasound plane is
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just beyond the tip of the needle. Next the needle is advanced toward the
target. Again, as soon as the needle breaks the plane of the beam, it
should be stopped and repeat the process until the target is reached
(Fig.18).
Out-of-plane technique
The needle should be adjusted. Probe should be held over the
target. The needle is advanced under the middle of the probe with a
shallow insertion angle. When the tip of the needle appears visible as a
bright dot on the screen, immediately needle advancement should be
stopped. Now the needle is withdrawn and redirected at a steeper angle.
We should advance until the tip is seen and stop again. The process is
repeated at steeper angles until the target is reached. The hyper echoic tip
can be viewed in a stepwise fashion as it descends toward the target
(Fig.19).
Visualizing the Injection
Probably the best marker for ruling out intravascular injection of
local anesthetic is ultrasound visualization of inject ate. If local anesthetic
spread is not obvious on the ultrasound screen, injection should be
immediately halted and needle tip position re-confirmed. Needle is
assumed intravascular if no spread of the local anesthetic is visualized.
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Dropout artifact:
This is caused because the entire foot of the probe is not in contact with
the skin surface (Fig.20).
Attenuation occurs as sound waves penetrate tissues. On the left
the image is dark, and on the right the distal gain has been increased to
make the distal portion of the image more visible. Other techniques to
view deeper structures are reducing the frequency and adjusting the focus
to a deeper position (Fig.21).
Needle misalignment is common and can lead to incorrect identification
of the needle tip. In the two ultrasound images the needle has not moved,
but because of misalignment the needle tip position appears different
(Fig.22).
Bayonet Effect:
The needle appears to bend as it passes through muscle and into the
local anesthetic pool (Fig.23).
Reverberation Artifact
When the needle is completely in-plane, it will have a shadow
below it. The ultrasound beam is bouncing between the anterior and
posterior walls of the needle, creating a “shadow” effect below the needle
(Fig.24).
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Intra neural Injection:
Injection near a nerve should produce a dark (anechoic) area of
local anesthetic around a nerve. Occasionally, we may get too close to a
nerve and actually insert the needle inside the nerve. During injection of
local anesthetic, the patient may or may not feel a paresthesia. If the
nerve does not expand during injection, the needle is likely outside of the
nerve. If the nerve expands during injection, the needle is likely intra
neural and injection should be immediately stopped and the needle
withdrawn from the nerve. Current thinking is that if the injection is sub-
epineural (outside covering of a nerve bundle) then there is only a small
chance for permanent injury. If the injection goes sub-perineural (i.e.,
inside a nerve fascicle), then the likelihood of prolonged neuropathy is
increased (Fig.25).
Positioning of the patient:
There are several important qualities to consider when positioning a
patient for an ultrasound guided nerve block:
1. Ultrasound probe and needle position—In-plane needle approaches
usually require slightly longer needles and, therefore, more space is
required to advance the needle.
2. Ultrasound machine location—Place the machine between the operator
and the patient so the patient, the screen, and the needle can be easily
viewed with minimal repositioning.
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3. Patient will be sedated.
When starting ultrasound guided regional anesthesia, most
operators use the dominant hand to advance the needle and the non-
dominant hand to hold the ultrasound probe. His hands should rest
comfortably during the block to steady the probe and needle.
Equipment and preparation:
Needle Type: Echogenic needles include
1) A 50 mm extended tube with an insulated needle. The tube that can be
easily attached with a syringe of local anesthetic,
2) Skin Preparation-Chlorhexidine, Betadine or alcohol.
3) Probe Cover For continuous indwelling catheters, full drape and full
probe covers are recommended to maintain strict aseptic technique. For
single-injection nerve blocks, probes can be covered with a clear adhesive
dressing (Fig.26).
Monitors:
Standard monitors for nerve block procedures are
a) Pulse oximeter,
b) ECG monitor (three leads) and
c) Noninvasive blood pressure.
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Time Out
Prior to block placement, a “time-out” should be performed to check for
correct
1. Patient identification
2. Surgery and surgery side
3. Block and block side
4. Monitors and equipment available
5. Patient position.
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OBJECTIVES
This is a study conducted to compare the effects of addition of
Dexmeditomedine to Levobupivacaine for Axillary brachial plexus block.
The effects will be studied in terms of:
 Onset of sensory blockade and motor blockade.
 Duration of sensory and motor blockade
 Complications / side effects if any
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REVIEW OF LITERATURE
History of brachial plexus block
The first brachial plexus block was performed by William Stewart
Halsted in1885, less than a year after Koller demonstrated the
anaesthetic properties of cocaine on the eye of a patient. Halsted exposed
the roots surgically under local Infiltration and injected each of them with
a small amount of dilute cocaine (0.1%) intra neutrally under direct
vision.(Fig.7) Only about 0.5 ml of local anaesthetic was required to
produce complete anesthesia. In 1897, Crile used a similar technique in
which the plexus was exposed under local anesthesia.  Just behind the
sterno mastoid muscle and cocaine injected into the nerve trunks under
direct vision which has done as a therapeutic measure in a 12 year old
boy who developed tetanic spasms following a compound fracture of the
forearm, later the technique was used to provide anesthesia for upper arm
surgeries.
1. Ishrat Hussain Mir, Abdul Hamid (2008) conducted a study on
adding butorphanol with lignocaine in axillary brachial plexus block and
demonstrated that adding butorphanol with lignocaine for brachial plexus
blockade provides a significant prolongation of the blockade.
2.Kenanet al63concluded that adding Dexmeditomedine to
Levobupivacaine in axillary brachial plexus block shortens sensory block
56
onset time, increases the sensory and motor block duration and time to
first analgesic use, and decreases total analgesic use with no side effects.
3. In a study by Sarita et al 22, they concluded that
Dexmeditomedine prolongs the duration of sensory and motor block
duration of analgesia and enhances the quality of block as compared with
clonidine when used as an adjuvant to Bupivacaine in peripheral nerve
block.
4. Aliye esmaoglu et al (2010) evaluated the effect of adding
Dexmeditomidine (100µg) to 0.5% Levobupivacaine for axillary brachial
plexus blockade. The primary endpoints were the onset and duration of
sensory and motor block and duration of analgesia. They concluded that
Dexmeditomidine added to Levobupivacaine for axillary brachial plexus
block shortens the onset time and prolongs the duration of the block and
the duration of postoperative analgesia.
5. Obayah et al61 studied the effect of Dexmeditomedine on the
duration of sensory blockade. They evaluated the effect of adding 1µg/kg
of dexmeditomedine to 0.25% bupivacaine on the duration of
postoperative analgesia in children who underwent repair of a cleft palate.
Conclusion of their study was Greater palatine nerve block with a
combination of Dexmeditomidine and bupivacaine increased the duration
of analgesia after repair of a cleft palate by 50% with no clinically
relevant side effects.
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6. Rachana Gandhi, Alka Shah and Patel conducted a prospective
double blind study to compare the postoperative analgesic efficacy and
safety of Dexmeditomidine (30µg) for brachial plexus blockade along
with bupivacaine (0.25%). Assessment of motor and sensory blockade,
pulse, systolic blood pressure, respiration and side effects were noted
every 5 minutes for first 30 minute and every 10 minute till end of
surgery. Duration of analgesia and incidence of various complications
following the procedure were observed. It was observed that in control
group onset of motor and sensory blockade was faster. Dexmeditomedine
group had better hemodynamic stability and greater postoperative
analgesia.
7. In a study of Amany S et al, 21 0.75 µg/kg of Dexmeditomidine
and plain bupivacaine were compared in USG guided infraclavicular
block. They found that dexmeditomidine reduced the time of onset of
sensory and motor block, increased the duration of analgesia, reduced the
VAS pain scores and finally decreased the supplemental needs of opioids.
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MATERIALS AND METHODOLOGY
Source of data:
A comparative study of USG guided axillary brachial plexus block
with levobupivacaine and levobupivacaine with dexmeditomedine was
carried out at Govt. Mohan Kumaramangalam Medical College Hospital
(GMKMCH) attached Govt. Mohan Kumaramangalam Medical College,
Salem. The patients belonged to the inpatient section of the Departments
of Plastic Surgery and Orthopedic Specialty. Sixty patients of the age
group 18 to 60 years of both sexes requiring both elective and emergency
surgery of the elbow, forearm &hand were selected and divided into two
groups of 30 patients each.
Methods of collection of data
Patients undergoing elective forearm and hand surgery will be
included in the study, after obtaining the ethical committee clearance.
Inclusion criteria
Patients belonging to age group 18-60 years with ASA grade I and
grade II undergoing elective operative procedure for upper limb surgeries
(i.e. elbow & forearm and hand surgeries.)
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Exclusion criteria
1. Patients who refuse.
2. Patients with history of bleeding disorders.
3. Patients with local infection at the site of block.
4. Patients with documented neuromuscular disorders.
5. Patients with respiratory compromise.
6. Patients with known allergy to local anaesthetic drugs.
7. ASA grade III and IV patients.
Mode of selection of cases:
Randomized prospective double blinded case control study
Allocation to different regimens:
Group A: Patients receiving 0.25% Levobupivacaine (40ml) + normal
saline (0.5ml).
Group B: Patients receiving 0.25% Levobupivacaine (40ml+
Dexmeditomidine (0.5ml).
The same volume of saline (placebo) corresponding to that of
Dexmeditomedine, was added to Levobupivacaine for the
Levobupivacaine + placebo group (Group A).
Sample size:
30 patients are taken as study and 30 patients are taken as control
(total 60 patients).
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Statistical data analysis:
Detailed descriptive analysis of socio demographic and clinical
parameters was done in the first step. The quantitative variables were
presented as mean ± standard deviation and the categorical variables were
presented as frequency and percentage. All the basic parameters were
compared between the two treatment groups. The time taken for onset of
anesthesia, duration of anesthesia, analgesic requirement etc. was
considered as primary outcome parameters. The hemodynamic and
respiratory parameters of the patients during and after anesthesia were
considered as secondary outcome variables. Both the outcomes were
compared between the two treatment groups, by calculating mean
differences. The statistical significance and 95% CI of these differences
was assessed by unpaired t-test. Microsoft excel and IBM SPSS
(Statistical Package for Social Sciences) version 21 were used for
statistical analysis Unpaired t-test was applied for demographic data,
hemodynamic parameters, onset and duration of sensory and motor
blockade and duration of analgesia. For assessing the quality Fisher exact
test was applied. P-value was considered significant if <0.05 and highly
significant if <0.001.
Equipment for axillary brachial plexus block:
1. 50mm insulated needle with catheter.
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2. 10ml syringe.
3. Local anaesthetic agent – Levobupivacaine without adrenaline /
Levobupivacaine with dexmeditomedine 0.5μg /kg
4. USG machine – Logiq- E by GE Health Care
High frequency small linear probe of 12 MHz
Procedure:
The procedure was explained to the patient and informed consent was
obtained. All aseptic precautions were taken throughout the procedure.
All the necessary equipment and emergency drugs were kept ready for
resuscitation in order to manage the toxic and untoward reactions
occurring during the procedure. The patients were brought to the
operation theatre and advised to lie in supine position with due comfort
on the tilt able (operating) table.
Pre-op heart rates (HR), Noninvasive blood pressure (NIBP),
Saturation pressure of oxygen (sPO2) were recorded. Intravenous access
was secured in the non-operative limb and a crystalloid was started. An
anesthesiologist experienced in performing ultrasound guided nerve
blocks gave the axillary block. He was blinded from the drug composition
of the local anaesthetic mixture used for the axillary block.
60 patients were randomly allotted into 2 groups, group A and group
B. All the patients received injection Midazolam 0.05mg/kg and injection
Fentanyl 0.5µg/kg intravenously15 minutes before the procedure.
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Axillary brachial plexus block was given with the patient lying supine
with the arm abducted from the body (90°) and flexed in the elbow
joint(90°)8.  The probe of ultrasound machine was placed over the
axillary region and axillary sheath will be identified. It was approached
using a 50 mm insulated needle with catheter for injecting the LA
solution. After repeated negative aspirations, 10 mL of local anaesthetic
solution which contains either Levobupivacaine alone or
Levobupivacaine with Dexmeditomedine was injected at each nerve
(radial, ulnar, median, musculoctaneous). Totally 40 ml given with either
0.5 ml normal saline or 0.5 ml of Dexmeditomedine which is 25 μg. A
thorough massage was given so that the drug distribution would be better.
The onset and duration of sensory loss and motor blockade were
studied. The loss of pinprick sensation was checked every 3 minutes till
the onset of loss of sensation and then every ½ hourly till the regain of
sensation. The motor blockade was assessed every 3 minutes till the loss
of movements and then every ½ hourly till the regain of movements.
Blood loss was assessed and IV fluids were given according to the loss.
Duration of surgery has been recorded. The intra- and post-operative
assessment was done by an anesthesiologist who had no idea of the drug
given.
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Parameters of comparison:
1) Onset of analgesia:
This was recorded as the interval between the time of injection and
the development of loss of sensation to pin prick. The dermatome
areas corresponding to the median nerve, radial nerve, ulnar nerve
and
musculo cutaneous nerves were checked at every minute till there
was complete loss of sensation.
Grading’s of sensory block:
Grade 0: Feeling of Sharp, pin prick sensation.
Grade 1: Analgesia (feeling of dull sensation).
Grade 2: Anesthesia (feeling of no pain at all)
2) Quality of analgesia:
The onset and completion of analgesia was tested by loss of
sensation to pin prick. The effect of analgesia after injection was
graded as:
Grade I: Good analgesia, sedatives were given only to relieve
apprehension.
Grade II: Inadequate, incomplete or patchy analgesia,
supplementation was given with N2O/O2, fentanyl, midazolam or
ketamine.
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Grade III: Very poor analgesia. General anesthesia was
administered.
The conclusion of Grade 11 was arrived when any one of the
segments supplied by four major nerves (radial, ulnar, median and
musculocutaneous nerves) did not have loss of sensation even after 30
minutes of the block.. They were supplemented with mask ventilation
with nitrous oxide, IV ketamine 0.5 mg/kg / fentanyl (1μg/ kg) and
midazolam (0.02 mg/kg). When there was no loss of sensation in more
than one nerve segment then it was considered a failed block. In such
case, general anesthesia was provided. Sedation component was recorded
by the Ramsay Sedation Score.
2) Degree of motor blockade:
The duration of motor block was called as the time interval
between the end of giving the drug and the recovery of complete motor
function of the elbow, wrist and finger movements.
Modified Bromage scale for upper extremities (3-point scale):
Grade I: Complete block, no active movement of entire elbow, forearm
and hand.
Grade II: Almost complete block, slight active movement of the fingers
retained.
Grade III: No block, nearly full range of movement retained.
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4) Duration of analgesia
Duration of analgesia was recorded with the help of Visual Analog
Scale (VAS) which ranges from 0 to 10.This scale was noted per every 60
minutes post-operatively till it comes to 5. Then the rescue analgesia was
provided. The drug used was injection diclofenac sodium (1.5 mg/kg)
intramuscularly. The time of administration was recorded.
The duration of sensory block was called as the time interval
between the end of drug injection and the complete resolution of pin prick
sensation on all nerve segments.
5) Complications: All patients were monitored for complications (if any)
during the intra-operative period and up to 48 hours post-operatively. The
observations and particulars of each patient were recorded in the
proforma enclosed.
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RESULTS AND OBSERVATION
A comparative study of Levobupivacaine alone and
Levobupivacaine with Dexmeditomidine in axillary brachial plexus block
was carried out on 60 patients divided into 2 groups of 30 patients each in
the age group of 18to60 years. The following observations were made.
Results:
A total of 60 participants were included in the final analysis. Out of the
60, 34 (56.7%) were randomized to intervention group A, to receive
0.25%Levobupivacaine+Normal saline (0.5 ml)). The remaining
26(43.3%) received intervention group B i.e. 0.25% Levobupivacaine +
Dexmeditomedine (0.5ml). (Table1)
Table1:
Descriptive Analysis Intervention groups (N=60)
Treatment group Frequency Percent
Group A
(0.25%Levobupivacaine+Normal
saline(0.5 ml))
34 56.7
Group B
(0.25%Levobupivacaine+Dexmedetomidin
e(0.5ml))
26 43.3
Total 60 100
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The socio demographic and anthropometric parameters were
comparable between two groups. Only minor differences existed in the
mean values of age and proportion of females. (Table2)
Table2:
Descriptive Analysis of Socio demographic parameters in study
groups (N=60)
Parameter Group A Group B
Age [mean(SD)] 37.47(SD) 34.19 (SD)
Sex
Male [Frequency (%)] 26 (%) 18 (%)
Female [Frequency (%)] 8 (%) 8 (%)
Anthropometry
Weight [mean(SD)] 67.59 (SD) 1.67(SD)
Height [mean(SD)] 67.85 (SD) 1.68(SD)
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Comparison of age distribution between two groups.
Comparison of sex distribution between two groups.
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There was no statistically significance difference in the baseline
hemodynamic and respiratory parameters in both the study groups.  So
the two study groups were comparable in terms of baseline hemodynamic
parameters. (Table 3)
Table3:
Baseline (pre-operative) hemodynamic and respiratory parameters in
both groups (N=60)
Parameter Group Mean
Mean
differ
ence
P
value
95% CI
Lower Upper
Pre-Operative
Heart Rate
Group A 82.15 -5.93 0.123 -13.519 1.659
Group B 88.08
Pre-Operative
Systole
Group A 133.47 0.124 0.980 -9.563 9.812
Group B 133.35
Pre-Operative
Diastole
Group A 84.41 -1.550 .566 -6.922 3.823
Group B 85.96
Pre-Operative
Respiratory
rate
Group A 13.47 -.645 .187 -1.611 .321
Group B 14.12
Pre-Operative
SPO2
Group A 99.71 -.025 .915 -.490 .440
Group B 99.73
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Comparison of pre-op heart rate between two groups
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Comparison of pre-op blood pressure between two groups
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The onset of sensory blockade (mean difference 0.04 minutes, p-value
<0.001) and motor blockade (mean difference 0.03 minutes, p-value
<0.001) were quicker in group B compared to group A. Both these
findings were statistically significant. Both the duration of sensory
blockade (mean difference 4.7 hours, p value <0.001), and motor
blockade (mean difference 1.8 hours, p value <0.001) were longer in
group B compared to group A and both these findings were statistically
significant. (Table 7)
Table7:
Comparison of onset and duration of anesthesia in both study groups
(N=60)
Parameter Group
Mea
n
Mean
differe
nce
P
value
95% CI
Lower Upper
Onset of
Sensory
Blockade
(minutes)
Group
A 0.07
0.04 <0.001 0.032 0:048Group
B 0.03
Onset of
Motor
Blockade
Group
A 0.10
0.03 <0.001 0.023 0.037Group
B 0.07
Duration
of
Sensory
Block
Group
A 8.91
-4.70 <0.001 -5.31 -4.09Group
B 13.61
Duration
of Motor
Block
Group
A 5.82
-1.82 <0.001 -2.37 -1.28Group
B 7.65
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Time taken for starting of regression (mean difference -1.37
minutes, p-value <0.108) was more in group B compared to group A, but
this finding was not statistically different. All other parameters related to
duration of anesthesia including time taken for full motor and sensory
recovery were longer in group B compared to group A. These differences
were statistically significant. (Table 8)
Table8:
Comparison of other anesthesia related parameters in both study
groups (N=60)
Parameter
Group
Mean Mean
differe
nce
P
val
ue
95% CI
Lower Upper
Time Taken for
starting of
Regression
Group
A
0.53 -1:37 .108 -3:37 0:22
Group
B
2.31
Time of full
sensory
recovery (mnts)
Group
A
10.01 -
4.7839
1
<0.
001
-
5.42451
-
4.14332
Group
B
14.79
Time of full
Motor
recovery(mnts)
Group
A
6.85 -1.946 <0.
001
-2.574 -1.318
Group
B
8.79
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There were statistically significant differences in the duration of
complete Analgesia, duration of effective analgesia and time of first pain
medication between the study groups. All these parameters were longer in
group B, compared to group A. (table 9)
Table 9:
Comparison of effectiveness of analgesia in both study groups
(N=60)
Parameter Group Mean
Mean
differen
ce
P value
95% CI
Lower Upper
Duration of
complete
Analgesia
(VAS at 0)
Group A 8.92 -
4.76029
<0.001 -5.38391
-
4.13668
Group B 13.69
Duration of
effective
Analgesia
(VAS  at 4)
Group A 9.96 -4.693
<0.001 -5.395 -3.990Group B 14.65
Time of First
Pain
Medication
(VAS  at 6)
Group A 12.00 -
4.36731
<0.001 -5.11333
-
3.62128
Group B 16.36
The average post anesthesia hemodynamic parameters were higher
in group A compared to group B. The difference in the heart rate and
diastolic blood pressure were statistically significant. The post anaesthetic
respiratory parameters were almost similar in both the study groups.
(Table 10)
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Table 10:
Comparison of Post anesthesia Hemodynamic Parameters (N=60)
Parameter Group
Mean Mean
differe
nce
P
value
95% CI
Lower Upper
Average Post
Anesthesia
Heart Rate
Group
A 74.1814 3.540 0.026 0.431 6.651
Group B 70.6410
Average Post
Anesthesia
Systole
Group
A 117.5392 2.632 0.315 -2.565 7.830
Group B 114.9071
Average Post
Anesthesia
Diastole
Group
A 73.8480 3.576 0.014 0.745 6.406
Group B 70.2724
Average Post
Anesthesia
Respiratory rate
Group
A 12.1299
-
.00792
0.909 -.14632 .13048
Group B 12.1378
Average Post
Anesthesia
SPO2
Group
A 99.9657
-
.00867
0.762 -.06567 .04833
Group B 99.9744
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Complications:
Complications Group A Group B
Axillary pain or discomfort 2 -
Bradycardia and
hypotension
- 3
Axillary site pain and discomfort was complained by 2 patients in
the group A whereas bradycardia and hypotension was observed in 3
patients in the group B which came to normal within 25minutes.
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DISCUSSION
Regional Anesthesia is becoming more popular especially with the
advent of safer drugs and techniques. Ultrasound has become more useful in
the last few decades. Since both the drugs namely, levobupivacaine and
dexmeditomidine are relatively newer in peripheral nerve block procedures,
an attempt has been made to compare the two.
Until now, the common adjuvant used with local anesthetics was the
opioids57, 62. More recently, α2 agonists have been used with good success.
They improve the quality and duration of block in peripheral nerve blocks.
The α2 agonists act through vasoconstriction, centrally acting pain relief,
anti-inflammatory effects, hyperpolarization, decrease in compound action
potential (CAP) and inhibition of voltage gate of sodium pump.
Age group:
Axillary block was conducted by Edson D. Carel in 1971 in pediatric
age group by B. Fitz Gerald in 1976, by R.K. Mehta et al., in 1979, Blasier
and White in 1996 and Colizza and Said in 1993, and supraclavicular
brachial block in combination with general anesthesia was used for micro
vascular surgery in children by Inberg P. et al., 1995.
In our study only adult patients were selected because of good patient
cooperation with regard to the procedure.
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Premedication
All the patients have received injection Midazolam 0.05mg/kg and
injection Fentanyl 0.5µg/kg intravenously15 minutes before the procedure.
This premedication was comparable with Sarita et al22 where there was no
premedication whereas Amany et al 21 have used midazolam of 1-2 mg and
fentanyl 50 – 100 µg (not based on per kg dose) in all of their patients
undergoing single shot infra clavicular block using bupivacaine with
dexmeditomidine (2012).
Ultrasound
Andrea et al27 compared the use of ultrasound and nerve stimulator for
axillary block. They found that ultrasound has supremacy in 98.5% of
successful blocks.
The findings of Vincent et al 28 and Christophe at al 29 also highlighted
the role of ultrasound in the success of axillary block.
In our study, we observed that almost all the 60 patients had Grade 1
block (Good analgesia, sedatives were given only to relieve apprehension).
This was made possible by the accuracy of the ultrasound in permitting
direct visualization of the nerves30.
Anaesthetic agent and dose
The recommended maximum dose for Levobupivacaine is 5mg/kg body
weight in peripheral nerve blocks. This dose recommendation serves only as
a base upon which a person using the drug in the technique should apply a
sensible judgment and make appropriate adjustment.
80
Kenan Kaygusuz et al (2012)62 and many others used 0.5%
Levobupivacaine for axillary block (Paresthesia technique) with a dose of
200 mg (4 mg/kg) without any toxic symptoms.
In our study Levobupivacaine was used as an anaesthetic agent for all the
cases in a concentration of 0.25%. We used Levobupivacaine in a dose of
2mg/kg body weight, with a total dose of only 100 mg, because of precise
location of nerves made possible by ultrasound.
Onset of action
In a study of Sarita et al (2012)22 where clonidine and Dexmeditomidine
were compared in supraclavicular block, mean onset time of motor block in
clonidine was 4.65 minutes whereas in Dexmeditomidine group was 3.87
minutes.  The mean onset time of sensory block in clonidine group was 2.3
minutes whereas in Dexmeditomidine group was 1.7 minutes.
In a study by Kenan et al63, when Dexmeditomedine was added with
Levobupivacaine in axillary block, there was no shortening of onset of
motor block whereas the onset of sensory block was shortened.
Keshav Govind Rao et al (2014)63 and Rachana Gandhi et al20 studied the
effects of Dexmeditomidine with bupivacaine in supraclavicular block.
They found that there was significant reduction of onset in the   duration of
motor and sensory blockade.
In our study the onset of sensory blockade (mean difference 0.04
minutes, p-value <0.001) and motor blockade (mean difference 0.03
minutes, p-value<0.001) were quicker in Levobupivacaine with
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Dexmeditomidine group compared to plain Levobupivacaine group. Both
these findings were statistically significant. The mean onset time of sensory
block in plain Levobupivacaine was 7 minutes whereas in Levobupivacaine
with Dexmeditomidine was 3 minutes. The mean onset time of motor block
with plain Levobupivacaine was 10 minutes whereas in Levobupivacaine
with Dexmeditomidine group was 7 minutes.
Thus, the durations of onset of sensory and motor block observed in our
study are comparable with the above mentioned studies done earlier.
Duration of analgesia
Amany S. et al21 compared bupivacaine alone and bupivacaine with
Dexmeditomedine in ultrasound-guided single injection infraclavicular
brachial plexus block. They reported that Dexmeditomidine group showed a
statistically important reduced time of onset of sensory block (13.2 vs. 19.4
min, P=0.003), increased duration of the sensory block (179.4 vs. 122.7
min, P=0.002), reduced time of onset of motor block (15.3 vs. 22.2 min,
P=0.003), prolonged duration of motor block (155.5 vs. 105.7 min,
P=0.002), prolonged duration of postoperative analgesia (403 vs. 233 min,
P=0.002) and reduced opioid requirements 48 hours after surgery.
Sarita et al22, Kenan et al63 and Aliye Esmaoglu et al17 also reported
similar effects in terms of prolongation of the duration of sensory and motor
blocks.
In our study time taken for starting of regression (mean difference -1.37
minutes, p-value <0.108) was more in Levobupivacaine with
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Dexmeditomedine compared to group levobupivacaine alone and this
finding was statistically significant. There were statistically significant
differences in the duration of complete analgesia, duration of effective
analgesia and time of first pain medication between the study groups. All
these three parameters were significantly prolonged in the group
Levobupivacaine with Dexmeditomidine.
Quality of analgesia
Memis et al in their study have showed that when Dexmeditomedine was
added with lignocaine for Biers block, it enhances the quality of analgesia.
In the study of Sarita et al, the quality of analgesia was 80% in patients
with Dexmeditomedine whereas it was only 40% in patients with clonidine
in supraclavicular block.
In our study, we graded the quality of analgesia into three grades and
recorded the observations. Grade I analgesia was observed in 84.4% of
patients in the levobupivacaine group whereas in the Levobupivacaine with
Dexmeditomedine group, 93.6% of the patients were found to achieve grade
I analgesia. The remaining patients in both the groups achieved Grade II
analgesia.
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Degree of motor blockade
Kenan et al observed that in both the groups with and without added
Dexmeditomedine, 78% of patients achieved, Grade I degree of motor
block.
In the present study, the degree of motor blockade observed in plain
Levobupivacaine was found to be Grade I (Complete block, no active
movements of entire elbow, forearm and hand) in 74.6% of patients and
86.6% in levobupivacaine with Dexmeditomidine patients. Grade II motor
blockade was found to be 25.4% and 13.4% in Levobupivacaine group and
Levobupivacaine with Dexmeditomedine group respectively.
These findings are comparable to the findings of the above mentioned
study.
Hemodynamic Parameters
Esmaoglu et al17 had observed bradycardia in their patient group in
which 100 μg of Dexmeditomedine was used with Levobupivacaine.
In our study, our observations show that the hemodynamic parameters
like heart rate and blood pressure were more in the optimal range in
Levobupivacaine with Dexmeditomidine group than plain Levobupivacaine
group. The respiratory parameters were almost similar in both the study
groups. Bradycardia and hypotension (transient) were observed in 3 patients
in the Levobupivacaine with Dexmeditomidine group.
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The incidence of bradycardia was lesser in our study (only 3 cases)
probably because of the lower dose of Dexmeditomidine we used. In our
study we used 0.5 μg /kg of Dexmeditomidine with a maximum of 40 μg.
Complications
Vikram Uday Lahori and Anjana Raina et al (2011) have reported
complications like accidental vascular puncture45 in 2 patients of axillary
block group.
In our study axillary pain or discomfort was the only complication in
both the groups. No other complications or significant adverse effects were
observed in both the study groups.
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Summary
We conducted a prospective randomized double blinded case control
study to compare Levobupivacaine and Levobupivacaine with
Dexmeditomidine in ultrasound guided axillary block for elbow, forearm &
hand surgeries.  Sixty patients  were  divided  into  2  groups  of  30
patients  each  and  axillary brachial plexus block with Levobupivacaine
alone  was performed on Group A patients and  with Levobupivacaine  and
Dexmeditomidine  on Group B patients. The patients were in the age group
of 18 to 60 years of either sex, coming for surgeries, either emergency or
planned, elbow & below the elbow joint in the orthopedics or plastic
surgery department.
The drugs used were Levobupivacaine hydrochloride in a concentration
of 0.25% and Dexmeditomidine at a dose of 0.5μg/kg. The concentration
was fixed and dose and volume varied according to the body weight of the
patient. Onset of analgesia was immediate with Dexmeditomidine with
Levobupivacaine (3-5 minutes) whereas the onset of analgesia took 8-10
minutes in patients with Levobupivacaine alone. The quality of analgesia
was Grade I in 76.6% patients with Levobupivacaine with
Dexmeditomidine whereas it was Grade I in 50% patient’s receiving
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Levobupivacaine alone. Degree of motor block was grade I in 56.6%
patients with Levobupivacaine with Dexmeditomidine as compared to only
26.6% patients with Levobupivacaine alone.
Duration of analgesia was found to be in the range of 8-10 hours with
Levobupivacaine alone, whereas duration with 14-16 hours was found with
Levobupivacaine with Dexmeditomidine.
Complications with both the drugs were found to be mild.
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Conclusion
Based on our observations, we conclude that in ultrasound guided
axillary block for elbow, forearm and hand surgeries, when compared to
plain Levobupivacaine, the mixture of levobupivacaine with
Dexmeditomidine produces
I. Statistically significant faster onset of sensory and motor blockade.
2. Statistically significant increase in duration of sensory and motor block.
3. Better grade of sensory and motor block, though this is not statistically
significant.
4. without much increase in the incidence of complications.
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PROFORMA
USG guided Axillary Brachial Plexus block for elbow, forearm and Hand
surgeries: A comparative study of Levobupivacaine & Levobupivacaine
with Dexmeditomidine:
Name:
Age:
Sex:
IP No:
ASA Status:                                                           Height:
Weight:
Diagnosis:
Surgery:
Date of Surgery:
Anesthesiologist:
PRE-OP EVALUATION
GENERAL EXAMINATION
History:
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Pallor:                 Icterus:                  Cyanosis:                   Clubbing:
Edema: Lymphadenopathy:
PR:                                                             BP:
RR:
SYSTEMIC EXAMINATION
CVS: CNS:
RS: P/A:
INVESTIGATIONS
Blood HB%:
FBS/RBS: Urea:                Creatinine:
Chest X-Ray: ECG:
PREMEDICATION
ANAESTHETIC TECHNIQUE
USG Guided:  10 ml each for radial, ulnar, median, musculocutaneous
nerve and medial cutaneous nerve of arm and forearm.  50 mm insulated
needle used for injecting the LA solution.
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Group A- 40 ml of 0.25% Levobupivacaine + 0.5 ml normal saline.
Group B- 40 ml of 0.25% Levobupivacaine + 0.5 ml Dexmeditomidine
(0.5 ml= 25 μg)
MONITORING OF VITALS
Intra-op:
Time      pre-op     I mnt 3     5   10    15      20    25      30     45     60 120
150
HR
BP
RR
SPO2
SUPPLIMENTATION
OBSERVATIONS: Time of injection of drug in to the axillary sheath:
SENSORY BLOCKADE:
Time of onset (The time interval between administrations of local
anesthetic solution to loss of pin prick sensation)
100
Duration of sensory block:
Duration of complete analgesia (Time of starting of regression / Return of
pinprick sensation / VAS is >0)
Duration of effective analgesia (Time for full Sensory Recovery / VAS is
>4):
Time to first pain medication (VAS>6):
MOTOR BLOCKADE:
Motor Blockade (Time of onset):
Motor Blockade (Degree/ Modified Bromage scale for upper
extremities on a 3-point scale): Grade 1 /2 /   3
Grade 0: Normal motor function with full flexion and extension of elbow,
wrist and fingers
Grade 1: Decreased motor strength with ability to move the fingers only
Grade 2: Complete motor block with inability to move the fingers
Motor Blockade (Duration of block):
Time for full motor recovery:
101
Quality of intra-op. analgesia (4 point modified Belzarena scale)
Grade 4: (Excellent) No complaint from patient
Grade 3: (Good) Minor complaint with no need for the supplemental
analgesics
Grade 2: (Moderate) Complaint that required supplemental analgesia
Grade 1: (Unsuccessful) Patient given general anesthesia
Grade 1   / 2 /   3 / 4
Complications
(Bradycardia, hypotension, dizziness, nausea, vomiting, dryness of mouth,
inadvertent vascular puncture etc.)
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PATIENT CONSENT FORM
Study title: USG guided Axillary Brachial Plexus block for elbow,
forearm and Hand surgeries A comparative study of Levobupivacaine &
Levobupivacaine with Dexmeditomedine.
Study Centre: Department of Anesthesiology, GMKMCH, Salem.
Participant’s Name:                                                                 Age:              IP
NO:
The details of the study have been provided to me in writing and explained
to me in my own language. I confirm that I have understood the above study
and had the opportunity to ask questions. I understand that my participation
in the study is voluntary and that I am free to withdraw at any time, without
giving any reason, without my medical care or legal rights being affected. I
agree not to restrict the use of any data or results that arise from this study
provided such a use is only for scientific purposes. I fully consent to
participate in the above study.
Signature of the participant with date:
Signature of the witness:
Signature &Name of the Anesthesiologist:
103
MASTER   CHARTS
S.No Name Age Sex Group IP No ASAStatus Ht Wt
Pre Op
(HR)
1 mnt
(HR)
3rd
mnt
(HR)
5th
mnt
(HR)
10th
mnt
(HR)
15 (HR) 20 (HR)
1 Sundhari 55 Female Group B 66582 1 1.6 70 118 112 95 95 72 70 66
2 Murugan 24 Male Group B 56530 1 1.76 70 76 74 72 68 68 70 72
3 Govindhan 55 Male Group A 59154 2 1.7 75 90 88 80 76 72 74 70
4 Pavunu 50 Female Group A 71024 2 1.55 90 88 76 78 74 70 68 67
5 Govindhan 18 Male Group B 70294 1 1.7 65 96 88 74 72 73 72 72
6 Babu 45 Male Group B 68928 1 1.7 80 84 82 76 74 73 72 72
7 Ramesh 27 Male Group A 70398 1 1.74 70 88 79 72 74 70 73 72
8 Rajeswari 36 Male Group A 69080 1 1.68 60 82 78 77 78 76 72 72
9 Kumar 30 Male Group B 69320 1 1.72 70 96 88 74 72 72 76 76
10 Ellappan 55 Male Group A 69080 1 1.67 60 86 84 78 78 84 77 76
11 KulanthaiVadivel. 58 Male Group A 70022 2 1.65 78 66 89 78 72 70 68 68
12 Thulasiraman 18 Male Group B 69874 1 1.7 60 102 96 84 78 72 72 76
13 chandraleka 19 Female Group B 73900 1 1.5 40 148 136 124 118 84 78 82
14 SundaraMoorthy 53 Male Group B 68920 1 1.67 70 68 68 66 61 58 57 57
15 Mayilsamy 31 Male Group B 69572 1 1.65 75 68 86 74 68 66 59 54
16 Nithya 30 Female Group B 67810 1 1.6 55 92 92 90 84 78 76 75
17 Subramanyan 40 Male Group A 52524 2 1.7 70 68 68 72 66 68 64 66
18 Kuppayee 50 Female Group A 64550 2 1.58 60 88 83 86 94 102 81 72
19 Kanjamalai 50 Male Group A 18782 1 1.65 74 62 63 62 66 62 64 59
20 Dhanam 40 Female Group B 69136 2 1.55 70 79 78 74 69 66 66 68
21 Kamala 25 Female Group B 53582 1 1.6 55 100 98 98 87 88 73 68
22 Vijayakumar 31 Male Group A 38128-OP 1 1.75 80 88 86 82 78 77 77 77
23 Gowtham 18 Male Group A 70294 1 1.76 60 78 78 77 78 75 76 77
24 Devan 54 Male Group A 73056 2 1.6 70 98 93 94 86 85 82 80
25 Saraswathy 48 Female Group A 42986 2- DM 1.55 70 78 78 77 75 76 75 74
26 Kumar 45 Male Group A 72720 1 1.68 75 96 92 88 86 87 84 82
27 subramani 50 Male Group B 59088 1 1.73 55 94 86 77 78 74 68 72
28 Venkatesh 49 Male Group A 47126-OP 1 1.68 70 82 82 80 78 77 81 73
29 Murugan raj 29 Male Group B 62244 1 1.76 75 78 77 72 66 65 62 58
30 Anbarasu 22 Male Group A 38028 1 1.7 62 58 58 57 60 58 59 60
31 Priya 19 Female Group A 39844 1 1.65 53 92 91 88 86 82 78 76
32 Utherasamy 48 Male Group B 30798 2 1.78 64 78 78 77 76 68 62 64
33 Ganeshan 35 Male Group B 54574 1 1.74 75 78 76 72 78 80 72 68
34 Thana kodi 26 Female Group A 57576 2 1.6 50 92 85 78 76 76 75 74
35 Madhu 50 Male Group B 49690 1 1.75 80 68 67 68 62 58 57 58
36 Selvi 55 Female Group A 71050 2 1.55 70 78 77 78 81 73 71 68
37 Santha 58 Female Group A 27810 1 1.5 60 76 76 74 73 76 72 72
38 Balu 26 Male Group B 49954 1 1.75 70 82 80 76 78 74 71 62
39 Nallakodi 46 Male Group A 36706 1 1.7 80 78 76 76 75 72 72 72
40 Kamala 25 Female Group A 53582 1 1.68 60 90 88 86 85 78 74 72
41 Sakthivel 19 Male Group A 58428 1 1.76 55 88 82 78 78 76 72 70
42 Indhumathi 19 Female Group B 70262 1 1.6 45 108 92 86 75 76 68 72
43 Narayanan 55 Male Group B 43490 2 1.8 85 72 70 68 66 65 68 68
44 Chinnaponnu 32 Female Group B 54142 2 1.58 70 102 98 92 86 77 74 73
45 vasanth 24 Male Group A 50720 1 1.75 70 82 81 77 72 66 63 68
46 saminathan 39 Male Group A 43602 1 1.74 85 66 66 73 72 72 76 75
47 Gopal 44 Male Group B 57720 1 1.72 78 88 87 85 81 77 75 72
48 Sathishkumar 25 Male Group A 63306 1 1.7 65 86 86 85 82 81 78 76
49 Balamurugan 26 Male Group A 70662 1 1.7 75 110 108 104 98 97 95 92
50 Nethaji 58 Male Group A 69876 2 1.72 78 68 68 67 66 67 65 64
51 Sengottaiyan 42 Male Group A 44922 1 1.72 68 78 78 77 78 76 75 76
52 Harish 18 Male Group A 43446 1 1.68 55 90 88 89 87 82 78 76
53 Manian 22 Male Group A 44100 1 1.76 62 82 82 80 76 78 78 76
54 sathish 19 male Group B 32430 1 1.78 63 82 82 80 78 72 74 72
55 Jeyaprakash 26 Male Group B 41564 1 1.75 79 78 78 76 77 78 74 64
56 Natesan 18 Male Group A 41513 1 1.68 55 83 83 82 78 75 76 72
57 Mani 45 Male Group B 23536 2 1.65 80 68 68 62 58 53 48 48
58 Naveen Kumar 18 Male Group A 27075 1 1.7 58 90 89 85 83 78 77 74
59 Govind 48 Male Group A 31458 1 1.64 75 68 68 70 67 66 68 67
60 Malarkodi 23 Female Group B 31017 1 1.65 65 87 86 84 78 77 73 72
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1 54 48 49 55 56 55 108 69 124 92 119 66 102 58 108 62 94 45 112 68 110 65
2 74 72 74 72 74 72 116 77 108 69 110 68 102 66 108 69 112 66 112 66 110 70
3 72 74 76 72 73 76 160 84 154 78 137 69 134 66 129 67 132 69 129 68 118 55
4 68 69 65 62 74 69 186 78 168 83 206 79 186 79 153 61 142 55 146 66 155 68
5 74 70 72 69 66 74 128 92 126 87 108 66 106 64 108 66 104 58 106 59 102 48
6 69 73 66 68 78 74 158 96 148 88 136 72 127 68 122 66 135 69 108 54 121 67
7 76 73 68 69 70 74 134 89 122 78 118 70 114 68 108 66 110 69 98 54 106 66
8 74 86 77 73 72 70 138 86 129 76 122 69 111 70 104 68 106 69 109 72 118 66
9 75 72 72 69 72 72 138 96 126 82 118 67 109 62 116 68 108 59 112 65 102 54
10 72 69 72 73 78 82 134 98 136 100 128 96 116 82 115 84 108 78 110 70 108 66
11 66 64 57 56 62 62 168 97 176 102 158 96 144 82 146 83 142 81 138 64 136 63
12 78 68 66 70 72 68 130 90 128 86 118 82 110 76 106 75 102 74 92 58 102 66
13 78 66 63 58 64 72 138 100 126 88 120 86 118 79 110 68 102 59 106 58 110 66
14 55 57 58 62 59 62 132 89 128 82 127 82 121 79 116 77 115 77 114 78 107 73
15 54 56 52 58 60 62 132 88 128 86 118 78 106 66 105 66 97 58 102 58 106 60
16 72 68 66 67 68 72 138 77 137 75 133 74 129 72 124 69 122 68 118 66 113 67
17 64 62 58 62 63 63 136 98 128 84 126 83 122 82 122 82 116 78 108 76 112 81
18 68 70 74 72 74 72 138 86 129 84 118 78 110 70 103 69 104 71 122 82 113 76
19 54 60 62 66 64 62 140 90 146 108 138 96 124 87 123 88 121 82 108 67 100 61
20 65 65 68 65 65 69 184 92 144 74 139 72 143 77 148 78 142 78 152 78 157 78
21 68 66 62 58 63 68 140 90 138 88 134 86 122 78 121 78 108 69 114 72 107 70
22 75 74 75 76 74 72 138 88 129 84 128 84 126 87 127 88 119 83 119 84 109 78
23 74 74 78 84 86 78 120 80 118 82 117 81 114 78 106 71 101 66 121 82 123 82
24 78 77 74 73 72 72 160 100 148 96 146 95 140 88 138 82 126 80 125 82 118 80
25 77 73 72 68 70 72 130 90 128 88 127 88 122 86 124 85 127 87 122 88 116 82
26 83 82 83 81 80 76 170 100 168 99 166 98 166 98 163 88 158 84 147 78 144 76
27 70 68 66 70 64 68 108 76 98 69 84 56 102 66 97 63 105 66 114 72 122 78
28 74 76 74 77 78 76 130 80 128 80 126 77 122 76 118 72 117 73 106 58 102 55
29 57 58 62 62 66 68 134 86 128 83 117 78 116 77 109 68 102 64 98 59 108 62
30 62 66 58 56 60 62 108 66 108 65 104 62 102 58 108 64 115 71 110 68 97 54
31 76 74 73 73 68 72 129 87 129 87 123 82 118 79 121 78 117 78 112 76 110 75
32 66 68 74 72 73 75 108 72 102 72 94 65 98 67 102 68 91 59 95 63 97 65
33 66 68 70 72 77 72 124 86 112 78 102 66 98 62 104 68 110 72 118 76 122 75
34 74 73 72 68 70 72 108 66 110 68 114 73 107 76 113 82 114 78 112 73 108 66
35 58 62 68 70 76 72 140 90 138 87 125 78 122 76 104 67 87 58 101 64 108 69
36 66 69 72 72 73 74 150 100 146 98 145 98 140 92 140 92 134 86 133 87 129 94
37 74 69 70 68 76 82 110 70 108 68 102 61 93 54 89 48 94 52 102 58 105 62
38 66 58 63 59 65 67 124 82 123 82 120 81 118 78 106 63 101 58 98 54 106 60
39 73 76 74 78 72 76 138 92 122 78 121 77 128 82 126 80 118 78 116 77 114 75
40 73 76 74 73 72 72 130 90 128 89 122 84 120 86 114 78 106 76 102 72 110 78
41 72 74 77 73 72 72 110 70 109 68 106 66 103 62 94 58 114 66 110 70 106 67
42 69 68 68 64 68 68 150 97 136 82 129 82 128 81 126 80 106 68 98 67 86 58
43 70 72 68 66 70 72 150 100 148 96 144 92 142 88 138 84 126 78 125 77 121 73
44 72 72 68 67 68 76 148 93 148 93 144 87 132 78 128 73 109 64 92 58 98 66
45 66 62 66 68 72 74 121 77 118 76 109 72 101 71 87 59 96 68 103 69 110 70
46 77 72 70 72 74 76 138 89 137 86 133 84 128 83 122 78 123 78 119 76 120 76
47 68 67 65 68 67 70 130 70 128 66 122 65 108 67 98 54 102 58 108 62 112 66
48 75 72 77 72 73 74 110 70 110 68 108 67 106 66 108 69 110 72 108 76 112 78
49 84 82 76 72 73 73 128 86 126 85 122 82 116 78 108 77 106 76 102 68 98 64
50 68 65 63 62 62 64 154 98 148 93 148 94 144 89 138 83 129 76 128 77 126 75
51 74 72 73 74 72 73 126 77 122 76 121 76 118 74 108 75 102 72 97 66 91 58
52 74 72 72 73 74 72 110 70 108 71 104 68 100 66 96 54 98 52 102 58 108 60
53 77 78 72 74 72 73 116 68 115 68 114 70 115 72 108 69 112 72 108 66 110 69
54 77 74 68 72 71 74 108 72 106 73 102 72 90 59 92 60 100 66 103 75 106 77
55 62 58 62 66 62 68 118 76 121 72 116 68 114 66 110 62 104 58 93 48 92 42
56 73 76 78 73 76 74 128 92 129 93 122 86 114 77 108 68 103 63 98 59 112 63
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Fig.1 Formation of brachial plexus
Fig.2 Anatomy of Brachial Plexus
Fig.3 Structure of Brachial Plexus
Fig.4 Brachial Plexus and its Terminal Branches
Fig.5 Dermatomal Distribution of Upper Limb
Fig.6 Pain Pathway
Fig.27 First brachial plexus anaesthesia at 1885.
Fig.9 Ultrasound Signals
Reflection from structures generates an
ultrasound signal. A structure perpendicular to
the beam will generate maximal reflection. A
nerve or a needle at a steep angle will cause less
reflection of sound waves to the probe.
Fig.10 Different types of probes 
A large, high-frequency linear probe (left);
a small linear probe (middle); and a large, low-
frequency curvilinear probe (right).
Fig.11 Using the highest frequency 
To achieve the best axial (vertical)
resolution, use the highest frequency possible.
This reduces the wavelength of the sound waves
and makes discrimination of small structures
possible. The tradeoff is poor tissue penetration.
The short wavelength/high-frequency sound
waves dissipate more energy, leading to less
tissue penetration.
Fig.12 Focus position affects image quality. 
The identical interscalene anatomy is
scanned on 2 images. On the left the focus is
set deep and on the right the focus is set
shallow. The nerves are easier to identify on
the right, where the focus is set at the same
depth as the nerve roots in the interscalene
groove.
Fig.15 Color Doppler can help identify vessels.
Tilting the probe can make vessels appear
to have flow or no flow. This is important to help
discriminate vessels from nerves. The images are
of the same artery with the probe at anacute
angle the upper image and the probe
perpendicular to the vessel in the lower image
Fig.13 Over- and Under-Gained Images. 
The center image demonstrates the bright
radial nerve in the center. The under-gained
image of the same nerve above is very dark, and
the over-gained image below is very bright. Both
over- and under-gain lose vital detail.
Fig.14 Time gain compensation (TGC) 
It adjusts brightness at various depths of
the screen. This can lead to artifact if not set
correctly. On the left the TGC is set appropriately
and the nerves are visible. On the right one of the
nerve roots is not visible because the TGC bar has
been moved across.
Fig.16 In-plane & Out-of-plane Needle Approach 
The upper images demonstrate an in-
plane needle approach. The lower images
demonstrate an out-of-plane needle approach.
Fig. 17 Out-of-plane  Technique - Sliding. 
Fig.18 Out-of-Plane Technique - Tilting.
Fig.19 Out-of-Plane Technique  - Adjust the Needle. 
Fig. 20 Dropout artifact is caused because the entire foot
of the probe is not in contact with the skin surface.
Fig. 21 Attenuation occurs as sound waves penetrate
tissues. On the left the image is dark, and on the right the
distal gain has been increased to make the distal portion of
the image more visible. Other techniques to view deeper
structures are reducing the frequency and adjusting the
focus to a deeper position.
Fig. 22 Needle misalignment is common and can lead
to incorrect identification of the needle tip. In the two
ultrasound images the needle has not moved, but
because of misalignment the needle tip position appears
different.
Fig.23 Bayonet effect.
The needle appears to bend as it passes through
muscle and into the local anesthetic pool.
Fig.25 Intraneural injection. 
The upper left and right pictures demonstrate before
and after an intraneural injection within the
musculocutaneous nerve (MC). In the lower two identical
pictures the nerve has been highlighted yellow.
Fig.24 Reverberation  artifacts.  
In this interscalene nerve block the reverberation
artifact beneath the needle obscures the image of the
interscalene groove and nerve roots beneath the needle tip
Fig.26 Equipment needed for an auxillary block
